Elisa Long

Assistant Professor in Decisions, Operations, and Technology Management

Phone: (310) 825-4458



Elisa Long is an Assistant Professor in Decisions, Operations & Technology Management. Prior to joining UCLA Anderson in 2013, she was a faculty member at the Yale School of Management. Professor Long's research interests include healthcare operations management, policy modeling, simulation and cost-effectiveness analysis of medical technologies. Her research integrates epidemiological modeling, economic analysis and decision making under uncertainty, with the goal of assessing the value of health interventions and assisting policymakers with allocating limited resources most effectively. Her current research projects relate to intensive care unit bed utilization and the optimal allocation of HIV-prevention resources. In prior work, she has investigated HIV-epidemic control measures in Russia, India, South Africa, Ghana and the United States.

At UCLA Anderson, Professor Long teaches Data and Decisions (MGMT 402) for the Full-time MBA and Fully Employed MBA (FEMBA) programs.

Research interests: Health Care Operations, Decision-analytic Modeling, Simulation, Dynamic Systems, Public Health Applications, Resource Allocation, Queuing in Hospital Settings


Ph.D. Management Science and Engineering, 2008, Stanford University
M.S. Management Science and Engineering, 2005, Stanford University
B.S. Operations Research, 2003, Cornell University
  • Long EF, Ganz PA.. (2015). Cost-effectiveness of Universal BRCA1/2 Screening. JAMA Oncology, In press.
  • Mathews KS, Long EF. (2015). A Conceptual Framework for Improving Critical Care Patient Flow and Bed Use. Annals of the American Thoracic Society, 12(6):886-894.
  • Alistar SS, Long EF, Brandeau ML, Beck EJ.. (2014). HIV Epidemic Control--A Model for Optimal Allocation of Prevention and Treatment Resources. Health Care Management Science, 17(2):162-181.
  • Eaton JW, Johnson LF, Salomon JA, Baernighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JAC, Humair S, Klein DJ, Long EF, Phillips AN, Pretorius C, Stover J, Wenger EA, Williams BG, Hallett TB.. (2012). HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa. PLoS Medicine, 9(7):e1001245.
  • Long EF, Stavert RR.. (2013). Portfolios of Biomedical HIV Interventions in South Africa: A Cost-Effectiveness Analysis. Journal of General Internal Medicine, 28(10):1294-1301.
  • Long EF.. (2011). HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis. PLoS ONE, 6(11):1-10.
  • Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E.. (2011). The Cost-Effectiveness of Symptom-Based Testing and Routine Screening for Acute HIV Infection in Men Who Have Sex with Men in the United States. AIDS,
  • Kaimal AJ, Little SE, Odibo AO, Stamilio DM, Grobman WA, Long EF, Owens DK, Caughey AB.. (2011). Cost-Effectiveness of Elective Induction of Labor at 41 Weeks in Nulliparous Women. American Journal of Obstetrics and Gynecology,
  • Long EF, Brandeau ML, Owens DK.. (2010). The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States. Annals of Internal Medicine,
  • Long EF, Brandeau ML, Owens DK.. (2009). Potential Population Health Outcomes and Expenditures of HIV Vaccination Strategies in the United States. Vaccine,
  • Long EF, Brandeau ML.. (2009). OR's Next Top Model: Decision Models for Infectious Disease Control" In Tutorials in Operations Research. Institute for Operations Research and Management Sciences,
  • Patil CG, Long EF, Lansberg MG.. (2009). Cost-Effectiveness Analysis of Mechanical Thrombectomy in Acute Ischemic Stroke. Journal of Neurosurgery,
  • Long EF, Vaidya NK, Brandeau ML.. (2008). Controlling Co-epidemics: Analysis of HIV and Tuberculosis Infection Dynamics. Operations Research,
  • Brandeau ML, Long EF, Hutton DW, Owens DK.. (2008). Optimal Spending on HIV Prevention and Treatment: A Framework for Evaluating the Cost-Effectiveness of HIV Prevention and Treatment Programs with Example Application to the India AIDS Initiative. In Optimization in Medicine and Biology,
  • Long EF, Brandeau ML, Galvin CM, Vinichenko T, Tole SP, Schwartz A, Sanders GD, Owens DK.. (2006). Effectiveness and Cost-Effectiveness of Strategies to Expand Antiretroviral Therapy in St. Petersburg, Russia. AIDS,